ArticleFrontiers in pharmacology2024

Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy.

Rajbharan Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.